Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Twelves

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|March 29, 1986
Folinic acid rescue and methotrexate toxicityC J Twelves
British Journal of Cancer|June 28, 2002
Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?C J Twelves, J Cassidy
British Journal of Cancer|May 6, 1998
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?N A Dobbs, C J Twelves
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?T L Wright, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Should cerebral metastases be treated by chemotherapy alone?C J Twelves, R L Souhami
British Journal of Cancer|November 16, 2002
Oral cancer treatment: developments in chemotherapy and beyondV J O'Neill, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Mouth cooling to prevent doxorubicin-induced stomatitisC J Twelves, A M Seymour
Breast (Edinburgh, Scotland)|February 18, 2004
Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancerR M Glasspool, C J Twelves
Endocrine-Related Cancer|September 25, 2003
Protein kinase C: a target for anticancer drugs?H J Mackay, C J Twelves
Journal of Chromatography|December 6, 1991
Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processorN A Dobbs, C J Twelves
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|March 29, 1986
Folinic acid rescue and methotrexate toxicityC J Twelves
British Journal of Cancer|June 28, 2002
Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?C J Twelves, J Cassidy
British Journal of Cancer|May 6, 1998
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?N A Dobbs, C J Twelves
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?T L Wright, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Should cerebral metastases be treated by chemotherapy alone?C J Twelves, R L Souhami
British Journal of Cancer|November 16, 2002
Oral cancer treatment: developments in chemotherapy and beyondV J O'Neill, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Mouth cooling to prevent doxorubicin-induced stomatitisC J Twelves, A M Seymour
Breast (Edinburgh, Scotland)|February 18, 2004
Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancerR M Glasspool, C J Twelves
Endocrine-Related Cancer|September 25, 2003
Protein kinase C: a target for anticancer drugs?H J Mackay, C J Twelves
Journal of Chromatography|December 6, 1991
Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processorN A Dobbs, C J Twelves
Pageof 7